Recon4IMD

Reconstruction and Computational Modelling for Inherited Metabolic Diseases

The European Recon4IMD project is developing computer-based models to accelerate and improve the diagnosis and personalized treatment of inherited metabolic diseases (IMDs). The goal is to create clinically validated decision-making tools that can be used in medical practice across Europe and approved by regulatory authorities. Recon4IMD is co-funded by the European Union's Horizon Europe Framework Programme (101080997), the Swiss State Secretariat for Education, Research and Innovation (23.00232), and by United Kingdom Research and Innovation (10083717 & 10080153).

Recon4IMD and the GENOMIT Consortium are collaborating in the field of OMICS analysis of biological samples.

mitoNET

Deutsches Netzwerk für mitochondriale Erkrankungen

The mitoNET network is a consortium of several university hospitals and research institutions from across Germany, as well as the nonprofit association mitoNET e.V., dedicated to researching the causes of mitochondrial diseases and developing effective therapies.
The mitoNET research consortium is a translation-oriented collaborative project in the field of rare diseases that was funded by the Federal Ministry of Education and Research (BMBF) from 2009 to 2015 and from 2019 to April 2023. It is a member of the Research for Rare Network.

Mitocon

Mitochondrial Disease Conference

The Mitocon network that brings together researchers and patients and supports a range of scientific projects, including the GENOMIT registry. Founded in 2007 it is part of a global network of associations and institutions dedicated to improving the diagnosis and treatment of mitochondrial diseases.

DZKJ

Das Deutsche Zentrum für Kinder- und Jugendgesundheit

The DZKJ research network of university hospitals and research institutions, currently operating at seven locations, coordinates and pools expertise to ensure optimal conditions for interdisciplinary research in the field of pediatrics and adolescent medicine. A key focus is on accelerating the translation of research findings into clinical practice. At the Munich site, 5 partner institutions with currently 21 research groups are working on research into metabolic and immune system disorders.

UMDF

United mitochondrial disease foundation

For 30 years, UMDF has built a network of the top clinicians, hospitals and researchers dedicated to fighting mitochondrial disease. UMDF is the largest funder of mitochondrial research outside of the federal government. In the last few years, discovery has streamlined the diagnosis for many and allowed designer therapies to be developed for several rare diseases that may be translatable to mitochondrial diseases.